Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial

Overview of attention for article published in Frontiers in oncology, August 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 18,701 followers.

RT @FrontOncology: New research: Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing…

06 Sep 2023

Reply Repost Favourite

RT @FrontOncology: New research: Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing…

06 Sep 2023

Reply Repost Favourite

New research: Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial: Introduction Studies that assessed the… #oncology https:

06 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.